About this FactMed analysis covering adverse side effect reports of RITUXIMAB patients who developed ADHESION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking RITUXIMAB reported ADHESION to the FDA. A total of 18129 RITUXIMAB drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between RITUXIMAB and ADHESION. In doing so, we compare RITUXIMAB with other drugs that cause ADHESION, to help you evaluate whether or not RITUXIMAB causes ADHESION. Likewise, this page shows the most highly-reported side effects of RITUXIMAB, so you can see if ADHESION ranks among RITUXIMAB's most well-known side effects.
Summary Statistics
Reports of RITUXIMAB causing ADHESION: 2
Reports of any side effect of RITUXIMAB : 18129
Percentage of RITUXIMAB patients where ADHESION is a reported side effect: 0.0110%

FDA reports of any drug causing ADHESION : 955
Average percentage for all medicated patients where ADHESION is reported as a complication: 0.0060%

Physician opinion on RITUXIMAB as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing RITUXIMAB:
RHEUMATOID ARTHRITIS ( 2132 patients )
DIFFUSE LARGE B-CELL LYMPHOMA ( 1855 patients )
NON-HODGKIN'S LYMPHOMA ( 1288 patients )
B-CELL LYMPHOMA ( 1199 patients )
CHRONIC LYMPHOCYTIC LEUKAEMIA ( 1057 patients )
MANTLE CELL LYMPHOMA ( 495 patients )
LYMPHOMA ( 429 patients )
IDIOPATHIC THROMBOCYTOPENIC PURPURA ( 361 patients )
SYSTEMIC LUPUS ERYTHEMATOSUS ( 253 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 224 patients )
DRUG USE FOR UNKNOWN INDICATION ( 172 patients )
BURKITT'S LYMPHOMA ( 166 patients )
HODGKIN'S DISEASE ( 83 patients )
MALIGNANT LYMPHOID NEOPLASM ( 81 patients )
RENAL TRANSPLANT ( 78 patients )
WALDENSTROM'S MACROGLOBULINAEMIA ( 68 patients )
HAEMATOLOGY TEST ABNORMAL ( 66 patients )
CHEMOTHERAPY ( 58 patients )
EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) ( 48 patients )
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS ( 47 patients )
IMMUNOSUPPRESSION ( 45 patients )
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER ( 44 patients )
VASCULITIS ( 42 patients )
WEGENER'S GRANULOMATOSIS ( 41 patients )
ACUTE LYMPHOCYTIC LEUKAEMIA ( 38 patients )
LYMPHOPROLIFERATIVE DISORDER ( 38 patients )
GRAFT VERSUS HOST DISEASE ( 29 patients )
SJOGREN'S SYNDROME ( 29 patients )
MULTIPLE SCLEROSIS ( 29 patients )
B-CELL SMALL LYMPHOCYTIC LYMPHOMA ( 28 patients )
STEM CELL TRANSPLANT ( 27 patients )
NON-HODGKIN'S LYMPHOMA STAGE IV ( 27 patients )
EVANS SYNDROME ( 26 patients )
CENTRAL NERVOUS SYSTEM LYMPHOMA ( 26 patients )
THROMBOTIC THROMBOCYTOPENIC PURPURA ( 26 patients )
ANTIPHOSPHOLIPID SYNDROME ( 26 patients )
NON-HODGKIN'S LYMPHOMA RECURRENT ( 25 patients )
BURKITT'S LEUKAEMIA ( 25 patients )
ANAEMIA HAEMOLYTIC AUTOIMMUNE ( 24 patients )
NEPHROTIC SYNDROME ( 23 patients )
B-CELL LYMPHOMA RECURRENT ( 23 patients )
CASTLEMAN'S DISEASE ( 23 patients )
JUVENILE ARTHRITIS ( 21 patients )
PEMPHIGUS ( 21 patients )
DRUG EXPOSURE DURING PREGNANCY ( 20 patients )
TRANSPLANT REJECTION ( 20 patients )
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV ( 20 patients )
HAIRY CELL LEUKAEMIA ( 19 patients )
CRYOGLOBULINAEMIA ( 18 patients )
PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA ( 18 patients )
LYMPHOMA AIDS RELATED ( 18 patients )
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ( 18 patients )
NEOPLASM MALIGNANT ( 18 patients )
LYMPHOCYTIC LEUKAEMIA ( 17 patients )
NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE ( 17 patients )
HAEMATOLOGICAL MALIGNANCY ( 17 patients )
MANTLE CELL LYMPHOMA RECURRENT ( 16 patients )
BONE MARROW CONDITIONING REGIMEN ( 16 patients )
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY ( 15 patients )
AUTOIMMUNE THROMBOCYTOPENIA ( 15 patients )
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT ( 15 patients )
NEUROMYELITIS OPTICA ( 14 patients )
MULTIPLE MYELOMA ( 14 patients )
PROPHYLAXIS AGAINST TRANSPLANT REJECTION ( 13 patients )
CHRONIC GRAFT VERSUS HOST DISEASE ( 13 patients )
CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT ( 13 patients )
LUPUS NEPHRITIS ( 13 patients )
SPLENIC MARGINAL ZONE LYMPHOMA ( 12 patients )
FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE IV ( 12 patients )
LYMPHOCYTIC LYMPHOMA ( 12 patients )
RENAL VASCULITIS ( 11 patients )
NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT ( 11 patients )
AUTOIMMUNE DISORDER ( 11 patients )
FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III ( 10 patients )
B-CELL LYMPHOMA STAGE IV ( 10 patients )
IMMUNOSUPPRESSANT DRUG THERAPY ( 10 patients )
MANTLE CELL LYMPHOMA STAGE IV ( 9 patients )
THROMBOCYTOPENIA ( 9 patients )
IMMUNOMODULATORY THERAPY ( 8 patients )
EPSTEIN-BARR VIRUS INFECTION ( 8 patients )
LEUKAEMIA ( 8 patients )
MYASTHENIA GRAVIS ( 7 patients )
LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA ( 7 patients )
HEPATITIS C ( 7 patients )
KIDNEY TRANSPLANT REJECTION ( 7 patients )
PREMEDICATION ( 7 patients )
ACQUIRED HAEMOPHILIA ( 7 patients )
NODAL MARGINAL ZONE B-CELL LYMPHOMA ( 7 patients )
ACUTE GRAFT VERSUS HOST DISEASE ( 7 patients )
T-CELL LYMPHOMA ( 7 patients )
FOCAL SEGMENTAL GLOMERULOSCLEROSIS ( 7 patients )
SCLERODERMA ( 7 patients )
MANTLE CELL LYMPHOMA REFRACTORY ( 6 patients )
B PRECURSOR TYPE ACUTE LEUKAEMIA ( 6 patients )
FACTOR VIII DEFICIENCY ( 6 patients )
DISEASE PROGRESSION ( 6 patients )
SCLERITIS ( 6 patients )
ARTHRITIS ( 6 patients )
PSORIATIC ARTHROPATHY ( 6 patients )
POLYMYOSITIS ( 6 patients )
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER ( 6 patients )
CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY ( 5 patients )
LIVER TRANSPLANT ( 5 patients )
OPSOCLONUS MYOCLONUS ( 5 patients )
BURKITT'S LYMPHOMA STAGE III ( 5 patients )
PEMPHIGOID ( 5 patients )
HAEMOLYTIC ANAEMIA ( 5 patients )
NEOPLASM ( 5 patients )
PROLYMPHOCYTIC LEUKAEMIA ( 5 patients )
RHEUMATOID VASCULITIS ( 5 patients )
B-CELL SMALL LYMPHOCYTIC LYMPHOMA STAGE II ( 5 patients )
FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE III ( 5 patients )
DIFFUSE LARGE B-CELL LYMPHOMA STAGE III ( 4 patients )
GLOMERULONEPHRITIS MEMBRANOUS ( 4 patients )
PROPHYLAXIS ( 4 patients )
MYELODYSPLASTIC SYNDROME ( 4 patients )
POLYARTHRITIS ( 4 patients )
BONE MARROW FAILURE ( 4 patients )
FACTOR VIII INHIBITION ( 4 patients )
TEMPORAL ARTERITIS ( 4 patients )
DERMATOMYOSITIS ( 4 patients )
HISTIOCYTOSIS HAEMATOPHAGIC ( 3 patients )
CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION ( 3 patients )
MICROSCOPIC POLYANGIITIS ( 3 patients )
URTICARIA CHRONIC ( 3 patients )
SURGICAL PRECONDITIONING ( 3 patients )
ACUTE LEUKAEMIA ( 3 patients )
T-CELL TYPE ACUTE LEUKAEMIA ( 3 patients )
ADJUVANT THERAPY ( 3 patients )
EPSTEIN-BARR VIRAEMIA ( 3 patients )
AUTOIMMUNE NEUTROPENIA ( 3 patients )
DIFFUSE LARGE B-CELL LYMPHOMA STAGE II ( 3 patients )
MATERNAL EXPOSURE DURING PREGNANCY ( 3 patients )
RAYNAUD'S PHENOMENON ( 3 patients )
GOODPASTURE'S SYNDROME ( 3 patients )
OVERLAP SYNDROME ( 3 patients )
NON-HODGKIN'S LYMPHOMA METASTATIC ( 3 patients )
MYELITIS TRANSVERSE ( 3 patients )
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED ( 3 patients )
DEMYELINATING POLYNEUROPATHY ( 3 patients )
MYOSITIS ( 3 patients )
ALLERGENIC DESENSITISATION PROCEDURE ( 3 patients )
PULMONARY AMYLOIDOSIS ( 2 patients )
BONE MARROW TRANSPLANT ( 2 patients )
DIFFUSE LARGE B-CELL LYMPHOMA STAGE I ( 2 patients )
PRECURSOR B-LYMPHOBLASTIC LYMPHOMA ( 2 patients )
COLD TYPE HAEMOLYTIC ANAEMIA ( 2 patients )
NEUROPATHY PERIPHERAL ( 2 patients )
FELTY'S SYNDROME ( 2 patients )
ACUTE MYELOID LEUKAEMIA ( 2 patients )
B-CELL TYPE ACUTE LEUKAEMIA ( 2 patients )
CYTOMEGALOVIRUS CHORIORETINITIS ( 2 patients )
NON-HODGKIN'S LYMPHOMA STAGE III ( 2 patients )
THERAPEUTIC PROCEDURE ( 2 patients )
ANTISYNTHETASE SYNDROME ( 2 patients )
EPIDERMOLYSIS ( 2 patients )
B-LYMPHOCYTE COUNT DECREASED ( 2 patients )
AIDS RELATED COMPLICATION ( 2 patients )
FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE II ( 2 patients )
NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT STAGE IV ( 2 patients )
HERPES SIMPLEX ( 2 patients )
ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY ( 2 patients )
LEUKAEMIC LYMPHOMA ( 2 patients )
PULMONARY FIBROSIS ( 2 patients )
SPLENIC MARGINAL ZONE LYMPHOMA STAGE IV ( 2 patients )
AMYLOIDOSIS ( 2 patients )
ORGAN TRANSPLANT ( 2 patients )
ANGIOCENTRIC LYMPHOMA ( 2 patients )
MIXED CONNECTIVE TISSUE DISEASE ( 2 patients )
BURKITT'S LYMPHOMA STAGE IV ( 2 patients )
PARANEOPLASTIC PEMPHIGUS ( 2 patients )
CORD BLOOD TRANSPLANT THERAPY ( 2 patients )
CELL-MEDIATED CYTOTOXICITY ( 2 patients )
NON-HODGKIN'S LYMPHOMA STAGE I ( 2 patients )
B-LYMPHOCYTE COUNT ( 2 patients )
EPIDERMOLYSIS BULLOSA ( 2 patients )
HEART TRANSPLANT REJECTION ( 2 patients )
FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE I ( 2 patients )
PSORIASIS ( 2 patients )
HEPATITIS C VIRUS TEST ( 2 patients )
SMALL INTESTINE CARCINOMA ( 2 patients )
OCULAR NEOPLASM ( 1 patients )
THYROID CANCER ( 1 patients )
AUTOIMMUNE PANCYTOPENIA ( 1 patients )
POLYNEUROPATHY ( 1 patients )
SPLENIC MARGINAL ZONE LYMPHOMA RECURRENT ( 1 patients )
ALVEOLAR PROTEINOSIS ( 1 patients )
GAMMOPATHY ( 1 patients )
PULMONARY HAEMORRHAGE ( 1 patients )
TRANSITIONAL CELL CARCINOMA ( 1 patients )
LYMPHADENOPATHY ( 1 patients )
OVARIAN CANCER ( 1 patients )
RENAL DISORDER ( 1 patients )
PRIMARY AMYLOIDOSIS ( 1 patients )
ANGIOEDEMA ( 1 patients )
PANCYTOPENIA ( 1 patients )
VASCULITIS GASTROINTESTINAL ( 1 patients )
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS ( 1 patients )
B-CELL LYMPHOMA STAGE I ( 1 patients )
COOMBS TEST POSITIVE ( 1 patients )
IMMUNE SYSTEM DISORDER ( 1 patients )
SYSTEMIC SCLEROSIS ( 1 patients )
ANKYLOSING SPONDYLITIS ( 1 patients )
FIBROUS HISTIOCYTOMA ( 1 patients )
ANTIFUNGAL PROPHYLAXIS ( 1 patients )
PERIPHERAL SENSORIMOTOR NEUROPATHY ( 1 patients )
RICHTER'S SYNDROME ( 1 patients )
WARM TYPE HAEMOLYTIC ANAEMIA ( 1 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 1 patients )
MALIGNANT HISTIOCYTOSIS ( 1 patients )
Drugs with high FDA adverse event association with ADHESION:

FOSAMAX (219 patients)
VIOXX (200 patients)
HUMIRA (129 patients)
REMICADE (102 patients)
PEGASYS (82 patients)
ACCUTANE (70 patients)
LIPITOR (58 patients)
NEURONTIN (55 patients)
ASPIRIN (46 patients)
AVONEX (45 patients)
SYNTHROID (44 patients)
PRILOSEC (42 patients)
LORAZEPAM (41 patients)
COPEGUS (40 patients)
FOLIC ACID (40 patients)
VITAMIN E (39 patients)
PAXIL (38 patients)
METHOTREXATE (37 patients)
CELEBREX (37 patients)
DIANEAL (37 patients)
PREMARIN (37 patients)
LISINOPRIL (32 patients)
HYDROCHLOROTHIAZIDE (31 patients)
LYRICA (30 patients)
FLOVENT (30 patients)
XANAX (28 patients)
LIORESAL (28 patients)
NORVASC (27 patients)
PREDNISONE (27 patients)
IBUPROFEN (27 patients)
ACTONEL (26 patients)
ALBUTEROL (26 patients)
[THERAPY UNSPECIFIED] (26 patients)
CALCIUM (UNSPECIFIED) (26 patients)
DIGOXIN (25 patients)
AMBIEN (25 patients)
PROTONIX (25 patients)
FUROSEMIDE (24 patients)
ATENOLOL (24 patients)
LASIX (23 patients)
OXYCONTIN (23 patients)
NEXIUM (23 patients)
FLEXERIL (22 patients)
ACETAMINOPHEN (21 patients)
FOSAMAX PLUS D (21 patients)
ZANTAC (21 patients)
ZOLOFT (21 patients)
EVISTA (21 patients)
VITAMIN D (21 patients)
CIPRO (20 patients)
LEVOTHYROXINE SODIUM (20 patients)
FORTEO (19 patients)
PREDNISONE TAB (19 patients)
LANOXIN (19 patients)
LEXAPRO (18 patients)
ACIPHEX (18 patients)
LORTAB (18 patients)
COUMADIN (18 patients)
OMEPRAZOLE (18 patients)
FLUOROURACIL (18 patients)
VERAPAMIL (17 patients)
VITAMINS (UNSPECIFIED) (17 patients)
PERCOCET (17 patients)
HYDROCODONE BITARTRATE (17 patients)
TRAZODONE HYDROCHLORIDE (17 patients)
CLARITIN (17 patients)
CLONAZEPAM (17 patients)
MULTI-VITAMIN (17 patients)
MYCOPHENOLATE MOFETIL (16 patients)
DETROL LA (16 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (16 patients)
SEROQUEL (16 patients)
AMITRIPTYLINE HYDROCHLORIDE (16 patients)
AMPICILLIN (16 patients)
ZOFRAN (16 patients)
VALIUM (15 patients)
CYANOCOBALAMIN (14 patients)
ALPRAZOLAM (14 patients)
WARFARIN SODIUM (14 patients)
VICODIN (14 patients)
ACYCLOVIR (13 patients)
LEVAQUIN (13 patients)
ROBAXIN (13 patients)
ALENDRONATE SODIUM (13 patients)
DECADRON (13 patients)
MORPHINE (13 patients)
VITAMIN B-12 (13 patients)
BACTRIM DS (13 patients)
ZELNORM (13 patients)
CIMZIA (13 patients)
ENTOCORT EC (13 patients)
ALTACE (12 patients)
VENTOLIN (12 patients)
K-DUR 10 (12 patients)
LEUCOVORIN CALCIUM (12 patients)
CYMBALTA (12 patients)
DEXAMETHASONE (12 patients)
MIRENA (12 patients)
GOLIMUMAB (12 patients)
HORMONES (UNSPECIFIED) (12 patients)
PREVACID (12 patients)
PRIMIDONE (12 patients)
CITALOPRAM HYDROBROMIDE (12 patients)
FENTANYL (12 patients)
VYTORIN (12 patients)
VITAMIN D (UNSPECIFIED) (11 patients)
ZOCOR (11 patients)
PREDNISOLONE (11 patients)
DOXORUBICIN HCL (11 patients)
POTASSIUM CHLORIDE (11 patients)
OYST CAL D (11 patients)
FAMOTIDINE (11 patients)
REGLAN (11 patients)
WELLBUTRIN (11 patients)
GABAPENTIN (11 patients)
OXYCODONE HCL (11 patients)
ZETIA (11 patients)
DULCOLAX (11 patients)
URBASON (11 patients)
CLOZARIL (11 patients)
CLONIDINE (11 patients)
RANITIDINE (11 patients)
REBIF (10 patients)
PREMPRO (10 patients)
YAZ (10 patients)
CLONOPIN (10 patients)
ESTRATEST (10 patients)
VITAMINS (10 patients)
ASCORBIC ACID (10 patients)
TOCILIZUMAB (10 patients)
DEPAKOTE (10 patients)
MIACALCIN (10 patients)
DOSTINEX (10 patients)
BACLOFEN (10 patients)
CELEXA (10 patients)
NITROSTAT (10 patients)
LANTUS (10 patients)
CALCIUM (10 patients)
DIFLUCAN (9 patients)
ENBREL (9 patients)
ONDANSETRON (9 patients)
TEGRETOL (9 patients)
PROMETHAZINE (9 patients)
INDAPAMIDE (9 patients)
ADVAIR DISKUS 100/50 (9 patients)
PLAVIX (9 patients)
LANSOPRAZOLE (9 patients)
TACROLIMUS (9 patients)
AMOXICILLIN (9 patients)
IMURAN (9 patients)
MULTI-VITAMINS (9 patients)
DIOVAN (9 patients)
MORPHINE SULFATE (9 patients)
CENTRUM (9 patients)
BIRTH CONTROL PILLS (9 patients)
ESTRADIOL (9 patients)
CALCIUM GLUCONATE (9 patients)
LUPRON DEPOT (9 patients)
FISH OIL (9 patients)
DICLOFENAC (9 patients)
CALCIUM CARBONATE (9 patients)
LOVENOX (8 patients)
MIRALAX (8 patients)
SALAGEN (8 patients)
CELECOXIB (8 patients)
ULTRAM (8 patients)
DEPO-PROVERA (8 patients)
TRAZODONE HCL (8 patients)
SK-ERYTHROMYCIN (8 patients)
MIRAPEX (8 patients)
VALTREX (8 patients)
TYLENOL (CAPLET) (8 patients)
YASMIN (8 patients)
RENAGEL (8 patients)
SERTRALINE HYDROCHLORIDE (8 patients)
CRESTOR (8 patients)
CARTICEL (8 patients)
AUGMENTIN '125' (8 patients)
DICLOFENAC SODIUM (8 patients)
AVASTIN (8 patients)
PENTASA (8 patients)
VELCADE (8 patients)
VANCOMYCIN (8 patients)
VINCRISTINE (8 patients)
PROGRAF (8 patients)
FLAGYL (8 patients)
UNCODEABLE ^UNCLASSIFIABLE^ (7 patients)
ELIDEL (7 patients)
FLOXIN OTIC (7 patients)
ACTOS (7 patients)
CLINDAMYCIN (7 patients)
IMIPRAMINE (7 patients)
OXALIPLATIN (7 patients)
AMITRIPTYLINE HCL (7 patients)
CIPROFLOXACIN (7 patients)
NIFEDIPINE (7 patients)
LAMICTAL (7 patients)
COZAAR (7 patients)
WARFARIN (7 patients)
FLORINEF (7 patients)
METOPROLOL (7 patients)
HUMALOG (7 patients)
BEVACIZUMAB (7 patients)
ISONIAZID (7 patients)
KLONOPIN (7 patients)
PROZAC (7 patients)
CALCICHEW (7 patients)
PYRIDIUM (7 patients)
RAMIPRIL (7 patients)
NUVARING (7 patients)
Most common side effects for patients taking RITUXIMAB:
FEBRILE NEUTROPENIA (1559 patients)
NEUTROPENIA (1099 patients)
PYREXIA (1037 patients)
PNEUMONIA (1006 patients)
THROMBOCYTOPENIA (857 patients)
ANAEMIA (801 patients)
DEATH (781 patients)
DRUG INEFFECTIVE (742 patients)
DIARRHOEA (688 patients)
NAUSEA (680 patients)
SEPSIS (662 patients)
PAIN (620 patients)
DYSPNOEA (596 patients)
INFECTION (578 patients)
ARTHRALGIA (526 patients)
FATIGUE (492 patients)
VOMITING (444 patients)
MYELODYSPLASTIC SYNDROME (408 patients)
PLATELET COUNT DECREASED (407 patients)
HYPOTENSION (396 patients)
WHITE BLOOD CELL COUNT DECREASED (384 patients)
PANCYTOPENIA (375 patients)
PULMONARY EMBOLISM (374 patients)
PLEURAL EFFUSION (372 patients)
DEHYDRATION (365 patients)
HEADACHE (363 patients)
MALAISE (354 patients)
LEUKOPENIA (349 patients)
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (341 patients)
RESPIRATORY FAILURE (341 patients)
PNEUMOCYSTIS JIROVECI PNEUMONIA (340 patients)
WEIGHT DECREASED (338 patients)
ASTHENIA (334 patients)
CYTOMEGALOVIRUS INFECTION (327 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (327 patients)
HAEMOGLOBIN DECREASED (325 patients)
SEPTIC SHOCK (307 patients)
PAIN IN EXTREMITY (297 patients)
OEDEMA PERIPHERAL (287 patients)
HYPERTENSION (283 patients)
HYPERSENSITIVITY (275 patients)
CHILLS (271 patients)
RENAL FAILURE (265 patients)
MULTI-ORGAN FAILURE (264 patients)
HEPATITIS B (262 patients)
ABDOMINAL PAIN (260 patients)
RASH (258 patients)
BONE MARROW FAILURE (257 patients)
COUGH (252 patients)
DIZZINESS (251 patients)
RHEUMATOID ARTHRITIS (249 patients)
NEUTROPHIL COUNT DECREASED (247 patients)
ATRIAL FIBRILLATION (242 patients)
RENAL FAILURE ACUTE (239 patients)
URINARY TRACT INFECTION (233 patients)
THERAPEUTIC RESPONSE DECREASED (226 patients)
DISEASE PROGRESSION (223 patients)
MUCOSAL INFLAMMATION (223 patients)
FALL (220 patients)
DEEP VEIN THROMBOSIS (219 patients)
PRURITUS (212 patients)
INTERSTITIAL LUNG DISEASE (212 patients)
DEPRESSION (211 patients)
CHEST PAIN (206 patients)
HERPES ZOSTER (204 patients)
SYNCOPE (203 patients)
GAIT DISTURBANCE (197 patients)
WEIGHT INCREASED (196 patients)
BACK PAIN (190 patients)
BONE PAIN (189 patients)
MYOCARDIAL INFARCTION (186 patients)
ACUTE MYELOID LEUKAEMIA (180 patients)
CONSTIPATION (179 patients)
TACHYCARDIA (178 patients)
INFUSION RELATED REACTION (173 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (173 patients)
NEUROPATHY PERIPHERAL (171 patients)
HAEMORRHAGE (164 patients)
CARDIAC FAILURE (159 patients)
CEREBROVASCULAR ACCIDENT (159 patients)
ERYTHEMA (156 patients)
LYMPHOMA (155 patients)
INSOMNIA (155 patients)
STOMATITIS (151 patients)
LYMPHOPENIA (151 patients)
JOINT SWELLING (151 patients)
CONFUSIONAL STATE (147 patients)
SOMNOLENCE (146 patients)
CARDIAC FAILURE CONGESTIVE (143 patients)
TUMOUR LYSIS SYNDROME (141 patients)
GASTROINTESTINAL HAEMORRHAGE (141 patients)
NEUTROPENIC SEPSIS (140 patients)
CONDITION AGGRAVATED (140 patients)
SWELLING (136 patients)
ALANINE AMINOTRANSFERASE INCREASED (135 patients)
FEBRILE BONE MARROW APLASIA (134 patients)
LYMPHOCYTE COUNT DECREASED (134 patients)
RASH ERYTHEMATOUS (133 patients)
SINUSITIS (129 patients)
RASH MACULO-PAPULAR (127 patients)
RECTAL HAEMORRHAGE (127 patients)
CARDIAC DISORDER (126 patients)
NEOPLASM MALIGNANT (125 patients)
NASOPHARYNGITIS (125 patients)
ALOPECIA (124 patients)
MUSCULAR WEAKNESS (124 patients)
LUNG INFECTION (123 patients)
VAGINAL HAEMORRHAGE (122 patients)
PURPURA (122 patients)
GRAFT VERSUS HOST DISEASE (122 patients)
HEPATIC FAILURE (122 patients)
DECREASED APPETITE (121 patients)
HYPERHIDROSIS (120 patients)
THROMBOSIS (120 patients)
HYPOKALAEMIA (119 patients)
RENAL IMPAIRMENT (117 patients)
C-REACTIVE PROTEIN INCREASED (116 patients)
HYPOXIA (116 patients)
LIVER DISORDER (114 patients)
GASTRITIS (114 patients)
ABDOMINAL PAIN UPPER (113 patients)
BLOOD CREATININE INCREASED (113 patients)
CONVULSION (111 patients)
HYPOGAMMAGLOBULINAEMIA (110 patients)
BLOOD PRESSURE INCREASED (108 patients)
PULMONARY OEDEMA (106 patients)
HAEMATOTOXICITY (105 patients)
ILL-DEFINED DISORDER (101 patients)
MELAENA (101 patients)
HYPOAESTHESIA (100 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (100 patients)
LUNG DISORDER (99 patients)
PNEUMONITIS (99 patients)
ANXIETY (95 patients)
DYSPHAGIA (94 patients)
LOWER RESPIRATORY TRACT INFECTION (94 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (94 patients)
IMMUNODEFICIENCY (93 patients)
DIFFUSE LARGE B-CELL LYMPHOMA (93 patients)
DYSPEPSIA (91 patients)
NON-HODGKIN'S LYMPHOMA (91 patients)
FUNGAL INFECTION (89 patients)
AGRANULOCYTOSIS (89 patients)
ARTHROPATHY (89 patients)
VASCULITIS (88 patients)
LYMPHADENOPATHY (87 patients)
STAPHYLOCOCCAL INFECTION (86 patients)
LEUKOCYTOSIS (86 patients)
DRUG INTERACTION (86 patients)
TREMOR (85 patients)
MALIGNANT NEOPLASM PROGRESSION (84 patients)
CHRONIC LYMPHOCYTIC LEUKAEMIA (83 patients)
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER (82 patients)
ORAL CANDIDIASIS (82 patients)
MUSCULOSKELETAL PAIN (81 patients)
HEPATIC FUNCTION ABNORMAL (81 patients)
EPISTAXIS (81 patients)
ASPERGILLOSIS (78 patients)
HYPONATRAEMIA (78 patients)
CELLULITIS (78 patients)
PULMONARY FIBROSIS (77 patients)
DRUG TOXICITY (76 patients)
GASTRIC ULCER HAEMORRHAGE (76 patients)
PARAESTHESIA (76 patients)
SYSTEMIC LUPUS ERYTHEMATOSUS (75 patients)
PNEUMOTHORAX (74 patients)
CARDIAC ARREST (73 patients)
LEUKOENCEPHALOPATHY (73 patients)
DEVICE RELATED INFECTION (73 patients)
INFLUENZA (73 patients)
ASCITES (73 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (73 patients)
B-CELL LYMPHOMA (72 patients)
URTICARIA (72 patients)
OEDEMA (72 patients)
ARRHYTHMIA (72 patients)
ENCEPHALOPATHY (71 patients)
HYPERGLYCAEMIA (71 patients)
MYALGIA (71 patients)
STEM CELL TRANSPLANT (70 patients)
NEUROTOXICITY (70 patients)
ACUTE RESPIRATORY FAILURE (69 patients)
LIVER FUNCTION TEST ABNORMAL (69 patients)
HYPOCALCAEMIA (69 patients)
BRONCHOPULMONARY ASPERGILLOSIS (69 patients)
LUNG INFILTRATION (69 patients)
BLOOD GLUCOSE INCREASED (69 patients)
BREAST CANCER (68 patients)
OROPHARYNGEAL PAIN (68 patients)
BRONCHITIS (68 patients)
LUNG NEOPLASM MALIGNANT (68 patients)
PULMONARY HYPERTENSION (68 patients)
PNEUMONIA BACTERIAL (67 patients)
PERIPHERAL SENSORY NEUROPATHY (67 patients)
PHARYNGITIS (66 patients)
CANDIDIASIS (66 patients)
BACTERIAL SEPSIS (65 patients)
ACUTE HEPATIC FAILURE (65 patients)
CEREBRAL HAEMORRHAGE (65 patients)
VISUAL IMPAIRMENT (65 patients)
BLOOD BILIRUBIN INCREASED (65 patients)
CATARACT (65 patients)
ARTHRITIS (64 patients)
ACUTE MYOCARDIAL INFARCTION (64 patients)
PULMONARY TOXICITY (64 patients)
HEART RATE INCREASED (63 patients)
HAEMATOCRIT DECREASED (62 patients)
BONE DISORDER (62 patients)
HEPATOTOXICITY (62 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (62 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for RITUXIMAB


Issue Description / Topic Timestamp
QUESTION
SEDATION
My dad is going to be sedated for first iv dose of rituximab why is this? He has Wegeners Gran. 2015-03-25 05:07:56
QUESTION
MYOPATHY
Dos Rituximab cause myopathy 2015-05-23 08:26:24
QUESTION
MYOPATHY
Do Rituximab cause myopathy 2015-05-23 08:28:03
QUESTION
AORTIC STENOSIS
IS RITUXIMAB SAFE IN PATIENTS WITH MODERATE AORTIC STENOSIS? 2015-06-19 12:11:56
QUESTION
HERNIA REPAIR
Patient is asymptomatic with large spleen and with a Hep C negative and with hernia repair one and half cm size what the patient decide either for splenectomy or single agent rituximab .please mail me at skjollyshoes@yahoo.com or call 9322875181 Mumbai india 2015-09-04 11:29:55
QUESTION
TACHYCARDIA
How to treat tachycardia in case where patient already taking metropolis? Thank you, Jill Gregory 2015-12-14 16:13:49
QUESTION
VITAMIN B12 INCREASED
Can you take b12 along side having rituximab infusions 2016-01-19 17:29:42
QUESTION
STOMATITIS
Is stomatitis a side effect of rituximab? 2016-05-12 08:30:35
QUESTION
LEFT VENTRICULAR HYPERTROPHY
does rituximab cause LEFT VENTRICULAR HYPERTROPHY 2016-05-24 15:46:27
QUESTION
PATERNAL DRUGS AFFECTING FOETUS
We are trying for a baby and my partner is due to have his first dose of retiximab is this safe for us? 2016-05-25 12:54:10
QUESTION
PATERNAL DRUGS AFFECTING FOETUS
We are trying for a baby and my partner is due to have his first dose of retiximab is this safe for us? 2016-05-26 15:30:19
QUESTION
PATERNAL DRUGS AFFECTING FOETUS
We are trying for a baby and my partner is due to have his first dose of retiximab is this safe for us? 2016-05-26 15:30:41
QUESTION
ACTINIC KERATOSIS
Relationship between use of rituxan and onset of inflamed actinic keratoses 2016-08-13 09:46:35
QUESTION
DYSTONIA
Hi there I already have a movement, and also on retuximab. After infusion I start with pins and needles all over that get progressively worse, I then begin to get dysonic traits. My hands close in and I'm unable to open them and this time my R leg also turned inward. I would like to know if anybody else has had similar experiences. Thanks Tracey. 2016-11-02 04:14:19
QUESTION
PULMONARY EMBOLISM
I have been on rituxamab for one year and never felt quite right. Last week I collapsed with multiple large pulmonary embolisms and health restored due to high levels of nursing at Intensive Care and at the respitory ward. Will not be having another infusion. Seeing biological nurse next month. Marian has anyone else had a similar experience 2016-11-24 14:22:58
QUESTION
PERSONALITY CHANGE
I've had 6 INFUSIONS ONCE A WEEK & ONE maintenance infusion of Rituximab my personality has gone from nice person to raging idiot. Is this possible? Has it happened to anyone else? I'm very mean & I've never been mean. It's very concerning to me and my family. 2016-12-02 13:25:43
QUESTION
SKIN CANCER
Prior to 2011 I had had two basel cell skin cancers over a 30 year period. In 2011 I was diagnosed with non hodgkins lymphoma and had radiation therapy and chemo using R-CHOP. Since then I have had on the average three skin cancers a year (mostly squamous cell). This started within 6 months of the treatment. So the incidence rate went from 1/30 per year to 3 per year--an increase by a factor of almost 100 !!! My Oncologist said it was due to the chemo, but did not give me additional information. I would greatly appreciate any information anyone could provide--especially links to research papers and studies.; and also any other help or advise. 2017-01-29 17:45:19
QUESTION
OSTEOPENIA
I was diagnosed with NHL splenic marginal zone in 2000. I had a splenectomy at that time with no further treatment. My oncologist considers my cancer in remission. In 2004, i had a septic infection with the vegetation lodging in my heart. This year, in 2017, I have gotten a diagnoses of osteopenia. It is more pronounced in the right shoulder area one of the areas that the septicemia infected. I also have what appears to be new bone growth in my right collarbone which grew when the sepsis was alive and thriving in my body. I would like to know if the osteopenia was a result of the septic infection, the NHL or a combination of the two. I am a 76 year old female. 2017-02-01 14:26:29
QUESTION
OSTEOPENIA
I was diagnosed with NHL splenic marginal zone in 2000. I had a splenectomy at that time with no further treatment. My oncologist considers my cancer in remission. In 2014, i had a septic infection with the vegetation lodging in my heart. This year, in 2017, I have gotten a diagnoses of osteopenia. It is more pronounced in the right shoulder area one of the areas that the septicemia infected. I also have what appears to be new bone growth in my right collarbone which grew when the sepsis was alive and thriving in my body. I would like to know if the osteopenia was a result of the septic infection, the NHL or a combination of the two. I am a 76 year old female. 2017-02-01 14:29:02
QUESTION
MUCOSAL INFLAMMATION
I wish I could read it but in KGhostview the cheatsheet comes up full of garbage. There are long lines of capital “T”s and &#88E0;2ࢭs. And, I think some of the text is being overwritten by the garbage. 2017-03-20 10:55:57
QUESTION
BLOOD FIBRINOGEN INCREASED
I received Rituximab in 2002 for NHL, which saved my life. I have been in remission for 15 years now, but my fibrinogen has reached a dangerously high level of 437. I need a safe way to reduce this number. I am avoiding inflammatory foods, such as meat, sugar, dairy, alcohol, caffeine, wheat, corn, soy, and peppers. I am also trying to get more vitamin A. What else can I do besides Bayer Aspirin, that is safe? 2017-04-01 20:17:02
QUESTION
TREMOR
I have been experiencing hand tremors since the first dose of rituximab on March 3rd 2017. One of the rheumatologist says he has never had anyone complain of hand tremors 2017-04-03 08:25:20
QUESTION
LATEX ALLERGY
I have a latex allergy. Can I take rituximab 2017-06-20 13:04:19
QUESTION
ORAL LICHEN PLANUS
can retuximap help oral lichen planus 2017-09-12 16:34:35
QUESTION
ABDOMINAL HERNIA REPAIR
can rituxan infusions cause an abdominal hernia? 2017-11-08 20:57:48
QUESTION
POLYMYALGIA RHEUMATICA
I had retuxan treatment for 18 mos following fludaribine for treatment of non Hodgkin lymphoma. I am in remission 8 years. I am now being treated for polymyalgia age 62, can retuxan have caused this? 2018-03-10 23:16:33

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ADHESION and RITUXIMAB, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking RITUXIMAB, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in RITUXIMAB. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for RITUXIMAB experts. If you are a healthcare provider experienced in prescribing RITUXIMAB, please register here.

Your online appointment book for Savannah Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use